Precigen (PGEN)
(Real Time Quote from BATS)
$1.87 USD
-0.06 (-3.11%)
Updated Aug 6, 2025 12:54 PM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PGEN 1.87 -0.06(-3.11%)
Will PGEN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PGEN
Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates
PGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Precigen, Inc. (PGEN) Just Flashed Golden Cross Signal: Do You Buy?
PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?
Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates
Other News for PGEN
Commit To Purchase Precigen At $1, Earn 111.7% Annualized Using Options
Unusually active option classes on open July 30th
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Largest borrow rate increases among liquid names
Largest borrow rate increases among liquid names